Variables | Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI of HR | P value | HR | 95% CI of HR | P value | ||
GSE37745 training set, n = 196 | |||||||
 Eight-lncRNA risk score | |||||||
  Low risk/high risk | 2.641 | 1.887–3.697 | <0.001 | 2.761 | 1.934–3.942 | <0.001 | |
 Age | |||||||
  ≤65/>65 | 1.355 | 0.977–1.878 | 0.069 | 1.427 | 1.024–1.986 | 0.035 | |
 Gender | |||||||
  Female/male | 1.096 | 0.789–1.523 | 0.585 | 0.913 | 0.640–1.303 | 0.616 | |
 Stage | |||||||
  I | 1 (reference) |  |  | 1 (reference) |  |  | |
  II | 1.220 | 0.793–1.875 | 0.366 | 1.169 | 0.758–1.802 | 0.479 | |
  III | 1.864 | 1.187–2.928 | 0.007 | 1.656 | 1.052–2.608 | 0.029 | |
  IV | 1.313 | 0.415–4.152 | 0.643 | 1.566 | 0.488–5.022 | 0.451 | |
 Subtype | |||||||
  Adenocarcinoma | 1 (reference) |  |  | 1 (reference) |  |  | |
  Large cell carcinoma | 0.891 | 0.520–1.528 | 0.675 | 0.782 | 0.449–1.360 | 0.383 | |
  Squamous cell carcinoma | 1.257 | 0.883–1.791 | 0.205 | 0.920 | 0.623–1.359 | 0.676 | |
GSE31210 testing set, n = 226 | |||||||
 Eight-lncRNA risk score | |||||||
  Low risk/High risk | 3.067 | 1.471–6.395 | 0.003 | 2.643 | 1.263–5.528 | 0.010 | |
 Age | |||||||
  ≤65/>65 | 2.584 | 1.313–5.083 | 0.006 | 3.685 | 1.800–7.544 | <0.001 | |
 Gender | |||||||
  Female/male | 1.519 | 0.780–2.955 | 0.219 | 1.143 | 0.402–3.246 | 0.802 | |
 Smoking status | |||||||
  No/Yes | 1.637 | 0.837–3.201 | 0.15 | 1.388 | 0.482–3.996 | 0.544 | |
 Stage | |||||||
  I/II | 4.232 | 2.175–8.236 | <0.001 | 4.363 | 2.161–8.811 | <0.001 | |
GSE50081 testing set, n = 181 | |||||||
 Eight-lncRNA risk score | |||||||
  Low risk/high risk | 1.795 | 1.127–2.859 | 0.014 | 1.752 | 1.014–3.026 | 0.044 | |
 Age | |||||||
  ≤65/>65 | 1.559 | 0.932–2.608 | 0.090 | 1.316 | 0.752–2.303 | 0.336 | |
 Gender | |||||||
  Female/male | 1.934 | 1.190–3.143 | 0.008 | 1.743 | 1.011–3.005 | 0.046 | |
 Smoking status | |||||||
  No/Yes | 1.387 | 0.659–2.916 | 0.389 | 1.054 | 0.476–2.333 | 0.897 | |
 Stage | |||||||
  I/II | 1.689 | 1.049–2.718 | 0.031 | 2.359 | 1.379–4.034 | 0.002 | |
 Subtype | |||||||
  Adenocarcinoma | 1 (reference) |  |  | 1 (reference) |  |  | |
  Large cell carcinoma | 1.326 | 0.479–3.671 | 0.587 | 1.094 | 0.376–3.184 | 0.870 | |
  Squamous cell carcinoma | 0.791 | 0.456–1.371 | 0.403 | 0.479 | 0.241–0.952 | 0.036 |